Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
Work (Reading, Mass.)|October 27, 2004
Loads on the lumbar spine during a work capacity assessment testM H Cole, P N Grimshaw, A M Burden
The Journal of Pharmacy and Pharmacology|November 20, 1998
Propylene glycol elicits anxiolytic-like responses to the elevated plus-maze in male miceH Q Lin, P M Burden, G A Johnston
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1995
Growth cones are actively influenced by substrate-bound adhesion moleculesS M Burden-Gulley, H R Payne, V Lemmon
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 2, 2011
The impact of pharmacist interventions on osteoporosis management: a systematic reviewM N Elias, A M Burden, S M Cadarette
Paediatric Drugs|December 14, 2024
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?Lukas Higi, Elisabeth Carydias, Andrea M Burden, et al.
Drug Safety|June 14, 2020
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBaseEnriqueta Vallejo-Yagüe, Stefan Weiler, Raphael Micheroli, et al.
Clinical and Translational Science|May 1, 2025
Integrating Sustainability Pillars Into Trial Design Decision-Making: Results of an International SurveyPritibha Singh, Oleksandr Sverdlov, Robert A Beckman, et al.
Clinical Pharmacology and Therapeutics|July 25, 2023
Design and Execution of Sustainable Decentralized Clinical TrialsPritibha Singh, Andrea M Burden, Fanni Natanegara, et al.
Archives of Osteoporosis|March 12, 2013
Variation in the days supply field for osteoporosis medications in OntarioAndrea M Burden, Anjie Huang, Mina Tadrous, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 22, 2015
Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary accessA M Burden, M Tadrous, A Calzavara, et al.
Pageof 30